Physician experiences in management of COVID-19-associated coagulopathy in pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis.
Stefan D JevticA Kinga Kinga MalinowskiMaha OthmanRezan A Abdul KadirPublished in: Journal of thrombosis and haemostasis : JTH (2021)
In the select population reported by our survey, CAC appears to be uncommon in pregnancy. Anticoagulation practices vary and may not reflect current guidelines. Venous thromboembolism was observed in some CAC patients despite prophylactic anticoagulation (including standard and weight-adjusted dosing). Urgent research is required to determine appropriate anticoagulant dosing and duration in pregnant women with COVID-19 infection.
Keyphrases
- venous thromboembolism
- atrial fibrillation
- pregnancy outcomes
- direct oral anticoagulants
- end stage renal disease
- primary care
- healthcare
- ejection fraction
- chronic kidney disease
- mental health
- coronavirus disease
- preterm birth
- newly diagnosed
- emergency department
- sars cov
- pregnant women
- body mass index
- pulmonary embolism
- prognostic factors
- polycystic ovary syndrome
- cross sectional
- weight loss
- metabolic syndrome
- climate change
- adipose tissue
- skeletal muscle
- respiratory syndrome coronavirus
- type diabetes
- body weight
- social media